Published in Antimicrob Agents Chemother on April 01, 1997
Drug resistance in leishmaniasis. Clin Microbiol Rev (2006) 7.35
The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev (2008) 5.32
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med (2006) 2.60
Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int (2011) 1.71
Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Negl Trop Dis (2011) 1.63
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res (2007) 1.52
Drug resistance in leishmaniasis. J Glob Infect Dis (2010) 1.52
Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother (1998) 1.44
DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother (2001) 1.39
Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother (2001) 1.34
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother (1999) 1.25
Leishmania antimony resistance: what we know what we can learn from the field. Parasitol Res (2011) 1.22
Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator. Antimicrob Agents Chemother (2001) 1.19
Visceral leishmaniasis treatment, Italy. Emerg Infect Dis (2003) 1.17
Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother (2007) 1.15
Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening. Antimicrob Agents Chemother (2005) 1.12
Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob Agents Chemother (1998) 1.12
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis (2005) 1.07
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. BMC Pharmacol (2002) 1.03
ABC proteins of Leishmania. J Bioenerg Biomembr (2001) 1.00
Antimony resistance in leishmania, focusing on experimental research. J Trop Med (2011) 0.97
Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole. Antimicrob Agents Chemother (2011) 0.95
Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. Indian J Med Res (2013) 0.92
Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother (1998) 0.92
Aquaglyceroporins and metalloid transport: implications in human diseases. Handb Exp Pharmacol (2009) 0.90
Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. Antimicrob Agents Chemother (2005) 0.87
Aquaglyceroporins: generalized metalloid channels. Biochim Biophys Acta (2013) 0.87
High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin. Antimicrob Agents Chemother (2001) 0.85
Flow cytometric detection of Leishmania parasites in human monocyte-derived macrophages: application to antileishmanial-drug testing. Antimicrob Agents Chemother (2000) 0.84
Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages. Parasitol Res (2016) 0.80
In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum. Parasitol Res (2008) 0.79
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area. Antimicrob Agents Chemother (2014) 0.79
The Effect of Vitis vinifera L. Leaves Extract on Leishmania infantum. Iran J Pharm Res (2013) 0.79
Comparison of tetrazolium salt assays for evaluation of drug activity against Leishmania spp. J Clin Microbiol (2014) 0.79
In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis. Dis Markers (2015) 0.76
Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacol Res (2016) 0.75
Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime. Adv Biomed Res (2017) 0.75
Multilocus microsatellite typing of Leishmania and clinical applications: a review. Parasite (2015) 0.75
Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs. Saudi Pharm J (2009) 0.75
Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate. Biomed Res Int (2017) 0.75
Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates. Parasitol Res (2014) 0.75
Evaluation of Correlation between the In Vitro Susceptibility of Field Isolates of Leishmania major and Clinical Outcomes of Meglumine Antimoniate Therapy in Fars Province, Iran. J Arthropod Borne Dis (2017) 0.75
Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp (1990) 3.61
An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J Antimicrob Chemother (1984) 1.83
An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis (1980) 1.70
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
Mechanisms of drug resistance in Leishmania. Parasitol Today (1993) 1.58
Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure. Exp Parasitol (1989) 1.42
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol (1994) 1.42
Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol (1992) 1.41
Phylogenetic relationships between Old World Leishmania strains revealed by analysis of a repetitive DNA sequence. Mol Biochem Parasitol (1995) 1.22
Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages. J Parasitol (1984) 1.20
Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans R Soc Trop Med Hyg (1985) 1.13
Molecular characterization of the ldmdr1 multidrug resistance gene from Leishmania donovani. Mol Biochem Parasitol (1993) 0.94
The immune dependence of chemotherapy. Parasitol Today (1991) 0.89
A homologous recombination strategy to analyze the vinblastine resistance property of the V-circle in Leishmania. Mol Biochem Parasitol (1994) 0.84
Recent advances in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg (1993) 0.84
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management]. Arch Pediatr (1996) 0.83
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol (1999) 2.72
Structure and activity of proteins from pathogenic fungi Phytophthora eliciting necrosis and acquired resistance in tobacco. Eur J Biochem (1989) 2.49
GSP-dependent protein secretion in gram-negative bacteria: the Xcp system of Pseudomonas aeruginosa. FEMS Microbiol Rev (1998) 2.17
Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol (1994) 2.04
Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS (1998) 1.94
ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett (2000) 1.81
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80
Nepalese origin of cholera epidemic in Haiti. Clin Microbiol Infect (2012) 1.77
Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett (1999) 1.68
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64
Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot. J Clin Microbiol (2000) 1.62
RpoS-dependent stress tolerance in Pseudomonas aeruginosa. Microbiology (1999) 1.60
Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol (2001) 1.58
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med (2009) 1.56
Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) (2008) 1.52
Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg (1995) 1.51
[Imported pediatric malaria in Marseille]. Arch Pediatr (1999) 1.50
Cardiac troponins in serum in chronic renal failure. Clin Chem (1994) 1.49
Cutaneous leishmaniasis of humans due to Leishmania (Viannia) naiffi outside Brazil. Trans R Soc Trop Med Hyg (1996) 1.46
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44
Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys (1993) 1.44
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
Ivermectin: a new therapeutic weapon in dermatology? Arch Dermatol (1999) 1.44
Isolation and characterization of a repetitive DNA sequence from Leishmania infantum: development of a visceral leishmaniasis polymerase chain reaction. Am J Trop Med Hyg (1993) 1.43
PCR enzyme-linked immunosorbent assay for diagnosis of leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol (1996) 1.42
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood (1999) 1.42
Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res (1998) 1.41
Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci Lett (1996) 1.40
Homoeopathy may not be effective in preventing malaria. BMJ (2000) 1.39
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol (1994) 1.38
Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol (2001) 1.35
How "should" we write guideline recommendations? Interpretation of deontic terminology in clinical practice guidelines: survey of the health services community. Qual Saf Health Care (2010) 1.32
Use of amplification and sequencing of the 16S rRNA gene to diagnose Mycoplasma pneumoniae osteomyelitis in a patient with hypogammaglobulinemia. Clin Infect Dis (1997) 1.32
The secretion apparatus of Pseudomonas aeruginosa: identification of a fifth pseudopilin, XcpX (GspK family). Mol Microbiol (1998) 1.31
A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol (1993) 1.30
HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR. Biochem Biophys Res Commun (1999) 1.30
[Specific serum IgAs in the diagnosis of toxoplasmosis]. Ann Pediatr (Paris) (1987) 1.30
Rapid identification of causative species in patients with Old World leishmaniasis. J Clin Microbiol (1997) 1.29
HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania. Clin Infect Dis (2000) 1.28
Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses. J Clin Microbiol (1999) 1.26
Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis (1995) 1.25
Synthesis and antibacterial activity of some imidazo[1,2-a]pyrimidine derivatives. Chem Pharm Bull (Tokyo) (1992) 1.25
In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C. Gastroenterology (1994) 1.24
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients. Cancer (1996) 1.23
Phylogenetic relationships between Old World Leishmania strains revealed by analysis of a repetitive DNA sequence. Mol Biochem Parasitol (1995) 1.22
Structure of iturine A, a peptidolipid antibiotic from Bacillus subtilis. Biochemistry (1978) 1.18
Role of molds in farmer's lung disease in Eastern France. Am J Respir Crit Care Med (2001) 1.18
Lytic enzymes in sporulating Bacillus subtilis. Biochem Biophys Res Commun (1976) 1.18
Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant (2005) 1.17
Genotyping of human cystic echinococcosis in Xinjiang, PR China. Parasitology (2006) 1.17
Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia (2012) 1.16
Assembly of XcpR in the cytoplasmic membrane is required for extracellular protein secretion in Pseudomonas aeruginosa. J Bacteriol (1999) 1.16
[Studies on the mycoside C 2 of the Mycobacterium avium. Structure determination]. Eur J Biochem (1971) 1.16
Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic Biol Med (2001) 1.16
Structural investigations on cell walls of Nocardia sp. The wall lipid and peptidoglycan moieties of Nocardia kirovani. Eur J Biochem (1972) 1.14
Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -- a Eurocord analysis. Br J Haematol (2001) 1.12
The biological diagnosis of leishmaniasis in HIV-infected patients. Ann Trop Med Parasitol (2003) 1.11
Are live saccharomyces yeasts harmful to patients? Lancet (1999) 1.11
Follow-up care for cancer survivors: the views of clinicians. Br J Cancer (2009) 1.10
Idiopathic thrombocytopenic purpura in two mothers of children with DiGeorge sequence: a new component manifestation of deletion 22q11? Am J Med Genet (1997) 1.10
Analysis of the flanking regions from different haemolysin determinants of Escherichia coli. Mol Gen Genet (1985) 1.09
Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood. Antimicrob Agents Chemother (2000) 1.09
Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest (1985) 1.08
Leishmania in bronchoalveolar lavage. Ann Intern Med (1991) 1.07
Assessment of the epidemiological status of Echinococcus multilocularis in foxes in France using ELISA coprotests on fox faeces collected in the field. Int J Parasitol (2001) 1.07
Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob Agents Chemother (1997) 1.07
Myosin light chain-actin interaction regulates cardiac contractility. Circ Res (1995) 1.06
[Structure and biogenesis of high molecular weight lipids from Nocardia asteroides]. Bull Soc Chim Biol (Paris) (1969) 1.05
Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol (1998) 1.04
A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med (1996) 1.04
Skin manifestations associated with toxocariasis: a case-control study. Dermatology (2000) 1.04
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03
Assessment of use of microsatellite polymorphism analysis for improving spatial distribution tracking of echinococcus multilocularis. J Clin Microbiol (2007) 1.03
Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains. Antimicrob Agents Chemother (1986) 1.03
c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Exp Cell Res (2001) 1.03
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring. Cancer Chemother Pharmacol (2007) 1.03
Very low seroprevalence of Lyme borreliosis in young Greek males. Eur J Epidemiol (2000) 1.03
Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer (1997) 1.03
EmsB, a tandem repeated multi-loci microsatellite, new tool to investigate the genetic diversity of Echinococcus multilocularis. Infect Genet Evol (2006) 1.02
Genetic typing of Echinococcus granulosus in Romania. Parasitol Res (2005) 1.02
Appearance of gamma-D-glutamyl-(L) meso-diaminopimealate peptidoglycan hydrolase during sporulation in Bacillus sphaericus. J Bacteriol (1974) 1.02
Arterioureteral fistula after extended resection of pelvic tumors: report of three cases and review of the literature. Ann Vasc Surg (1992) 1.02
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol (1993) 1.02
Phospholipid composition and phenotypic correction of an envC division mutant of Escherichia coli. J Bacteriol (1977) 1.01
Effect of the lipopeptide antibiotic, iturin A, on morphology and membrane ultrastructure of yeast cells. FEMS Microbiol Lett (1995) 1.01
Leishmania infantum and L. major in Algeria. Trans R Soc Trop Med Hyg (1997) 1.01
Surveillance of leishmaniases in France, 1999 to 2012. Euro Surveill (2013) 1.01
A novel mechanism for thalassaemia intermedia. Lancet (2002) 1.01
Microbial degradation of metal complexed cyanides and thiocyanate from mining wastewaters. Environ Pollut (1994) 1.01
[Ala4]surfactin, a novel isoform from Bacillus subtilis studied by mass and NMR spectroscopies. Eur J Biochem (1994) 1.00
Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1993) 1.00